Description

Rymoti 10 mg tablets contain Enalapril Maleate, an angiotensin-converting enzyme inhibitor used in the treatment of hypertension and selected cardiovascular conditions.

Enalapril inhibits the conversion of angiotensin I to angiotensin II, reducing vasoconstriction and helping lower blood pressure.

The 10mg strength provides an additional treatment option for patients requiring individualized blood pressure control. In selected patients with symptomatic heart failure, Enalapril may improve clinical outcomes and reduce the risk of hospitalization.

Enalapril is also indicated for clinically stable patients with asymptomatic left ventricular dysfunction to reduce progression to symptomatic heart failure.

Verified Therapeutic Indications

  • Hypertension.

  • Symptomatic congestive heart failure.

  • Asymptomatic left ventricular dysfunction in selected clinically stable patients.

Dosage & Administration

Reference prescribing information describes a usual adult maintenance range for hypertension of 10–40mg daily, administered once daily or in two divided doses.

For heart failure, the dosing schedule and titration differ. The physician determines the appropriate regimen based on blood pressure, kidney function, and clinical response.

Side Effects

Persistent dry cough, dizziness, headache, fatigue, hypotension, elevated potassium, and kidney function changes.

Contraindications & Precautions

Enalapril can cause serious fetal harm and should not be used during pregnancy. Patients with a history of ACE inhibitor-associated angioedema must not receive it.

Avoid use with aliskiren in patients with diabetes. Monitor renal function and serum potassium, particularly when used with diuretics or potassium supplements.

Packaging: 10mg | 20 Tablets (2 × 10)